8 May 2026
Aspen Insulin approval marks a milestone for diabetes care in South Africa, ensuring supply security with locally made insulin.
4 September 2025
Understand Aspen Unlocking Value efforts as CEO Stephen Saad addresses the decline in share price and targets business improvements.
4 March 2025
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.